Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Rabia Shahswar, Gernot Beutel, Razif Gabdoulline, Christian Koenecke, Dominik Markel, Matthias Eder, Michael Stadler, Gudrun Gohring, Brigitte Schlegelberger, Arne Trummer, Juergen Krauter, Felicitas Thol, Michael Heuser

Journal title: Annals of Hematology

Journal publisher: Springer Verlag

Published year: 2020

DOI identifier: 10.1007/s00277-020-04181-5

ISSN: 0939-5555